|4Sep 16, 5:25 PM ET

Dahl Andrew M. 4

4 · Edwards Lifesciences Corp · Filed Sep 16, 2024

Insider Transaction Report

Form 4
Period: 2024-09-13
Dahl Andrew M.
SVP, Corporate Controller
Transactions
  • Award

    Common Stock

    2024-09-13+2,9204,690.783 total
Footnotes (1)
  • [F1]These restricted stock units were granted on September 13, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Documents

1 file
  • 4
    doc4.xmlPrimary